Delivery Order SPE2DB22D2211-SPE2DB25FSENQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Levothyroxine 100 MCG vials under a firm fixed-price contract with a ceiling value of $4,231.47. This is a non-set-aside competitive award with an ultimate completion date of September 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Levothyroxine Sodium, a thyroid hormone replacement medication. This firm fixed-price delivery order, valued at $9,454.63, is scheduled for completion by October 3, 2025, with fulfillment based at the contractor's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.66 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 137 mcg tablets (100-count units) with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on July 21, 2025. The contractor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 30, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,723.68 with an ultimate completion date of September 2, 2025, represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,109.69 from the Defense Logistics Agency (DLA) to supply 1,000 tablets of 125 mcg levothyroxine under an indefinite delivery contract. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 5, 2023. As a leading pharmaceutical distributor, Amerisourcebergen Drug Corp regularly obtains delivery orders to supply medications and medical supplies to DLA Troop Support...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $30,240 delivery order by the Defense Logistics Agency to provide 137 microgram levothyroxine tablets. The firm fixed price order is for 90 tablets and will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania between July 12-13, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency routinely issues delivery orders against its...
- The Defense Logistics Agency Troop Support Medical awarded a $58,380 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 tablets of 25 mcg Levothyroxine sodium. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 13-14, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor, which will fulfill this order for the thyroid medication to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $775 to Amerisourcebergen Drug Corporation to supply 90 count bottles of 125 microgram levothyroxine tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 6-7, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department of Defense, this delivery order is...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $75,450 to Amerisourcebergen Drug Corporation for 4561686986 levothyroxine 75 microgram tablets. Under the terms of the order, Amerisourcebergen will deliver 90 tablets to a facility in Conshohocken, Pennsylvania, with performance required between August 3rd and 4th of 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's stockpile of prescription...
- The Defense Logistics Agency awarded a $97,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562091858 Levothyroxine Sodium 112 mcg tablets in 1000 count bottles. The order is to deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania by September 11, 2023 in support of DLA programs. Amerisourcebergen will serve as the prime contractor, with performance taking place at its corporate headquarters. No set aside designation or subcontractors...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSENQDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Levothyroxine 25 MCG tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,006.96, represents a non-competitive, non-set-aside award and will be completed by September 10, 2025. The place of performance is located at the company's corporate office in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical support to military healthcare systems globally. The IDC enables DLA to procure a broad range of pharmaceutical products, including generic medications such as Levothyroxine, to support Defense Health Agency operations and other federal healthcare customers. This award demonstrates the company's critical role as a primary distributor of essential medications within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/9/25 |